Overcoming the Causes (and Consequences) of Chronic Hyperkalemia
By Annenberg Center for Health Sciences
Chronic hyperkalemia has several possible causes, including impaired renal excretion of potassium due to a decrease in mineralocorticoid activity, often resulting from renin-angiotensin-aldosterone system inhibitor (RAASi) therapy. While limiting potassium intake and avoiding the use of RAASi therapy are common strategies to manage patients who develop chronic hyperkalemia, both have important negative consequences on patient outcomes, particularly related to the kidneys. Sodium polystyrene sulfonate has often been used to bind potassium, but limited effectiveness and gastrointestinal toxicity
Overcoming the Causes (and Consequences) of Chronic HyperkalemiaFeb 04, 2022
00:00
06:39
Other Treatment Considerations
<ul>
<li>Finerenone</li>
<li>Team care</li>
</ul>
<li>Finerenone</li>
<li>Team care</li>
</ul>
Feb 04, 202206:39
Potassium-binding Medications
- Safety & efficacy of patiromer
- Safety & efficacy of sodium zirconium cyclosilicate
Feb 04, 202210:37
RAAS Inhibitor Therapy
- Real-world use of RAAS inhibitor therapy
- Benefits & limitations of RAAS inhibitor therapy
Feb 04, 202217:44
Course Introduction
<ul>
<li>Potassium homeostasis</li>
<li>Differential diagnosis of hyperkalemia</li>
<li>Consequences of hyperkalemia</li>
</ul>
<li>Potassium homeostasis</li>
<li>Differential diagnosis of hyperkalemia</li>
<li>Consequences of hyperkalemia</li>
</ul>
Feb 04, 202213:15
Faculty Introduction
Biff F. Palmer, MD
Professor of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas
Feb 04, 202201:15